<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37477126</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1791-3004</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Molecular medicine reports</Title><ISOAbbreviation>Mol Med Rep</ISOAbbreviation></Journal><ArticleTitle>Analysis of glucocorticoid receptor and microRNAs expression in pathological renal tissues.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">169</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3892/mmr.2023.13056</ELocationID><Abstract><AbstractText>Glucocorticoid receptor (GR) is expressed in normal renal podocytes; however, its expression differs among renal diseases. The expression of GR as well as its epigenetic regulators microRNA (miR)30a, miR24 and miR370 was studied in the renal tissues of patients with systemic lupus nephritis (LN), minimal changes disease (MCD) and pauci-immune glumeronephritis (PIN). A total of 51&#xa0;patients undergoing renal biopsy and 22 nephrectomised controls with no history of parenchymal renal disease were recruited from the Clinic of Nephrology and Renal Transplantation of General Laikon hospital between November 2016 and March 2019. All patients were newly-diagnosed and they were na&#xef;ve of any treatment. The mRNA and protein expression were analyzed through reverse transcription-quantitative PCR and immunohistochemistry respectively. Written consent was obtained from all participants. <i>GR</i> mRNA expression was significantly reduced in all pathological samples compared with the 'normal' renal tissues used as controls (P=0.023 for LN, P=0.05 for MCD and P=0.004 for PIN). Similarly, GR protein expression was lower in all pathological samples (&gt;6 GR positive podocytes/glomerulus in 50% of patients with LN and MCD and 18% with PIN) compared with controls (&gt;6 positive podocytes/glomerulus in all the controls). PIN samples presented significantly lower <i>GR</i> mRNA and protein expression compared with LN and MCD samples. No significant differences were observed in the miR30a expression when comparing pathological with 'normal' renal samples. miR24 and miR370 expression demonstrated statistically significant difference in all pathological compared with 'normal' tissues. Moreover, <i>GR</i> expression was not significantly associated with either LN disease activity score or the response to the treatment. <i>GR</i> and miR24 expression was significantly reduced whereas miR370 significantly increased in all pathological compared with 'normal' renal tissues implying their protentional role in nephritis pathogenesis and treatment. Analysis of larger samples are required for more robust statistical analysis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Angelousi</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1st Department of Internal Medicine, Unit of Endocrinology, Laikon Hospital, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liapis</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>1st Department of Pathology, National and Kapodistrian University of Athens, Laikon Hospital, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gazouli</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Biology, Department of Basic Medical Sciences, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kofotolios</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Nephrology and Renal Transplantation, National and Kapodistrian University of Athens, Laikon Hospital, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakellariou</LastName><ForeName>Stratigoula</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>1st Department of Pathology, National and Kapodistrian University of Athens, Laikon Hospital, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boletis</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Nephrology and Renal Transplantation, National and Kapodistrian University of Athens, Laikon Hospital, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinaki</LastName><ForeName>Smaragdi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology and Renal Transplantation, National and Kapodistrian University of Athens, Laikon Hospital, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Mol Med Rep</MedlineTA><NlmUniqueID>101475259</NlmUniqueID><ISSNLinking>1791-2997</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011965">Receptors, Glucocorticoid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C526503">MIRN370 microRNA, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011965" MajorTopicYN="N">Receptors, Glucocorticoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009402" MajorTopicYN="Y">Nephrosis, Lipoid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">glucocorticoid receptor</Keyword><Keyword MajorTopicYN="N">miR24</Keyword><Keyword MajorTopicYN="N">miR30a</Keyword><Keyword MajorTopicYN="N">miR370 systemic lupus nephritis</Keyword><Keyword MajorTopicYN="N">minimal changes disease</Keyword><Keyword MajorTopicYN="N">pauci-immune glumeronephritis</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>21</Day><Hour>13</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37477126</ArticleId><ArticleId IdType="pmc">PMC10433714</ArticleId><ArticleId IdType="doi">10.3892/mmr.2023.13056</ArticleId><ArticleId IdType="pii">169</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yan K, Kudo A, Hirano H, Watanabe T, Tasaka T, Kataoka S, Nakajima N, Nishibori Y, Shibata T, Kohsaka T, et al. Subcellular localization of glucocorticoid receptor protein in the human kidney glomerulus. Kidney Int. 1999;56:65&#x2013;73. doi: 10.1046/j.1523-1755.1999.00503.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.1999.00503.x</ArticleId><ArticleId IdType="pubmed">10411680</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodwin JE. Role of the glucocorticoid receptor in glomerular disease. Am J Physiol Renal Physiol. 2019;317:F133&#x2013;F136. doi: 10.1152/ajprenal.00217.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00217.2019</ArticleId><ArticleId IdType="pmc">PMC6692724</ArticleId><ArticleId IdType="pubmed">31166704</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu DF, Moon M, Lanning LD, McCarthy AM, Smith RJH. Clinical features and outcomes of 98 children and adults with dense deposit disease. Pediatr Nephrol. 2012;27:773&#x2013;781. doi: 10.1007/s00467-011-2059-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-011-2059-7</ArticleId><ArticleId IdType="pmc">PMC4423603</ArticleId><ArticleId IdType="pubmed">22105967</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett CMF, Troxell ML, Larsen CP, Houghton DC. Membranous glomerulonephritis with crescents. Int Urol Nephrol. 2014;46:963&#x2013;971. doi: 10.1007/s11255-013-0593-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-013-0593-x</ArticleId><ArticleId IdType="pubmed">24217802</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharmeen S, Cassol C, Kato H. ANCA-associated necrotizing glomerulonephritis overlapping with mesangial proliferative lupus nephritis refractory to plasmapheresis, steroid pulse therapy, and a combination of mycophenolate mofetil and rituximab. Case Rep Rheumatol. 2018;2018:3076806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6276453</ArticleId><ArticleId IdType="pubmed">30581646</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Zhang M, Huang X, Zhang L, Zeng C, Zhang J, Liu Z, Tang Z. Therapeutic mechanism of glucocorticoids on cellular crescent formation in patients with antiglomerular basement membrane disease. Am J Med Sci. 2017;354:145&#x2013;151. doi: 10.1016/j.amjms.2017.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2017.04.015</ArticleId><ArticleId IdType="pubmed">28864372</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Hindmarch CCT, Rogers M, Campbell C, Waterfall C, Coghill J, Mathieson PW, Welsh GI. RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways. Sci Rep. 2016;6:35671. doi: 10.1038/srep35671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep35671</ArticleId><ArticleId IdType="pmc">PMC5075905</ArticleId><ArticleId IdType="pubmed">27774996</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazs&#xf3; A, Szappanos &#xc1;, R&#xe1;sonyi R, Nagy E, Farkas A, V&#xe1;rnai B, Pat&#xf3;cs A, Kiss E, Po&#xf3;r G. Polymorphisms of human glucocorticoid receptor gene in systemic lupus erythematosus: A single-centre result. Clin Rheumatol. 2019;38:1979&#x2013;1984. doi: 10.1007/s10067-019-04478-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-019-04478-5</ArticleId><ArticleId IdType="pubmed">30850964</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahbar Saadat Y, Hejazian SM, Nariman-Saleh-Fam Z, Bastami M, Poursheikhani A, M Shoja M, Ardalan M, Zununi Vahed S. Glucocorticoid receptors and their upstream epigenetic regulators in adults with steroid-resistant nephrotic syndrome. Biofactors. 2020;46:995&#x2013;1005. doi: 10.1002/biof.1680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1680</ArticleId><ArticleId IdType="pubmed">33031585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponticelli C, Locatelli F. Glucocorticoids in the treatment of glomerular diseases: Pitfalls and pearls. Clin J Am Soc Nephrol. 2018;13:815&#x2013;822. doi: 10.2215/CJN.12991117.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.12991117</ArticleId><ArticleId IdType="pmc">PMC5969489</ArticleId><ArticleId IdType="pubmed">29475991</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RM. The steroid and thyroid hormone receptor superfamily. Science. 1988;240:889&#x2013;895. doi: 10.1126/science.3283939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3283939</ArticleId><ArticleId IdType="pmc">PMC6159881</ArticleId><ArticleId IdType="pubmed">3283939</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Cidlowski JA. The human glucocorticoid receptor: One gene, multiple proteins and diverse responses. Steroids. 2005;70:407&#x2013;417. doi: 10.1016/j.steroids.2005.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.steroids.2005.02.006</ArticleId><ArticleId IdType="pubmed">15862824</ArticleId></ArticleIdList></Reference><Reference><Citation>De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: Molecular mechanisms for gene repression. Endocr Rev. 2003;24:488&#x2013;522. doi: 10.1210/er.2002-0006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2002-0006</ArticleId><ArticleId IdType="pubmed">12920152</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkenfeld SR, Lin C, Frigo DE. Communication between genomic and non-genomic signaling events coordinate steroid hormone actions. Steroids. 2018;133:2&#x2013;7. doi: 10.1016/j.steroids.2017.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.steroids.2017.11.005</ArticleId><ArticleId IdType="pmc">PMC5864526</ArticleId><ArticleId IdType="pubmed">29155216</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamal Y, Badawy A, Swelam S, Tawfeek MSK, Gad EF. Glomerular glucocorticoid receptors expression and clinicopathological types of childhood nephrotic syndrome. Fetal Pediatr Pathol. 2017;36:16&#x2013;26. doi: 10.1080/15513815.2016.1225872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15513815.2016.1225872</ArticleId><ArticleId IdType="pubmed">27690709</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SH, Park SY, Li JJ, Kwak SJ, Jung DS, Choi HY, Lee JE, Moon SJ, Kim DK, Han DS, Kang SW. Glomerular glucocorticoid receptor expression is reduced in late responders to steroids in adult-onset minimal change disease. Nephrol Dial Transplant. 2008;23:169&#x2013;175. doi: 10.1093/ndt/gfm575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfm575</ArticleId><ArticleId IdType="pubmed">17890747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Gou X, Jiang T, Ouyang J. The effects of microRNAs on glucocorticoid responsiveness. J Cancer Res Clin Oncol. 2017;143:1005&#x2013;1011. doi: 10.1007/s00432-017-2388-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00432-017-2388-4</ArticleId><ArticleId IdType="pubmed">28286901</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton SA, Jones SW, Kurowska-Stolarska M, Clark AR. The role of microRNAs in glucocorticoid action. J Biol Chem. 2018;293:1865&#x2013;1874. doi: 10.1074/jbc.R117.000366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R117.000366</ArticleId><ArticleId IdType="pmc">PMC5808749</ArticleId><ArticleId IdType="pubmed">29301941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease. Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group: KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100((4S)):S1&#x2013;S276.</Citation><ArticleIdList><ArticleId IdType="pubmed">34556256</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(&#x2212;Delta Delta C(T)) method. Methods. 2001;25:402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman DD, Urowitz MB, Doris F, Lewandowski K, Anhorn K. Glucocorticoid receptors in systemic lupus erythematosus. J Rheumatol. 1991;18:681&#x2013;684.</Citation><ArticleIdList><ArticleId IdType="pubmed">1865413</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshima H. Studies on the glucocorticoid receptor in human peripheral lymphocytes. II. Regulation by glucocorticoid. Nihon Naibunpi Gakkai Zasshi. 1986;62:1298&#x2013;1305. (In Japanese)</Citation><ArticleIdList><ArticleId IdType="pubmed">3803635</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomidou O, Vlachoyiannopoulos PG, Kominakis A, Kalofoutis A, Moutsopoulos HM, Moutsatsou P. Glucocorticoid receptor, nuclear factor kappaB, activator protein-1 and C-jun N-terminal kinase in systemic lupus erythematosus patients. Neuroimmunomodulation. 2006;13:194&#x2013;204. doi: 10.1159/000100474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000100474</ArticleId><ArticleId IdType="pubmed">17347585</ArticleId></ArticleIdList></Reference><Reference><Citation>Kino T, De Martino MU, Charmandari E, Mirani M, Chrousos GP. Tissue glucocorticoid resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol. 2003;85:457&#x2013;467. doi: 10.1016/S0960-0760(03)00218-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-0760(03)00218-8</ArticleId><ArticleId IdType="pubmed">12943736</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahran AM, Aly SS, Elsayh KI, Badawy A, Gamal Y. Glucocorticoid receptors expression and histopathological types in children with nephrotic syndrome. Ren Fail. 2014;36:1067&#x2013;1072. doi: 10.3109/0886022X.2014.917936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022X.2014.917936</ArticleId><ArticleId IdType="pubmed">24896642</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalaby SA, El Idrissy HM, Safar RA, Hussein ST. Glucocorticoid receptors and the pattern of steroid response in idiopathic nephrotic syndrome. Arab J Nephrol Transplant. 2012;5:13&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">22283861</ArticleId></ArticleIdList></Reference><Reference><Citation>Kee YK, Nam BY, Jhee JH, Park JT, Lim BJ, Yoo TH, Kang SW, Jeong HJ, Han SH. The association of glomerular glucocorticoid receptor expression with responsiveness to corticosteroid treatment in IgA nephropathy. Am J Nephrol. 2019;50:187&#x2013;195. doi: 10.1159/000502327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000502327</ArticleId><ArticleId IdType="pubmed">31408863</ArticleId></ArticleIdList></Reference><Reference><Citation>Xian Y, Dong L, Jia Y, Lin Y, Jiao W, Wang Y. miR-370 promotes high glucose-induced podocyte injuries by inhibiting angiotensin II type 1 receptor-associated protein. Cell Biol Int. 2018;42:1545&#x2013;1555. doi: 10.1002/cbin.11048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.11048</ArticleId><ArticleId IdType="pubmed">30095204</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal A, Pan Y, Navarro F, Dykxhoorn DM, Moreau L, Meire E, Bentwich Z, Lieberman J, Chowdhury D. miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat Struct Mol Biol. 2009;16:492&#x2013;498. doi: 10.1038/nsmb.1589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1589</ArticleId><ArticleId IdType="pmc">PMC2853019</ArticleId><ArticleId IdType="pubmed">19377482</ArticleId></ArticleIdList></Reference><Reference><Citation>Manvati S, Mangalhara KC, Kalaiarasan P, Srivastava N, Bamezai RNK. miR-24-2 regulates genes in survival pathway and demonstrates potential in reducing cellular viability in combination with docetaxel. Gene. 2015;567:217&#x2013;224. doi: 10.1016/j.gene.2015.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.05.003</ArticleId><ArticleId IdType="pubmed">25943634</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson S, MacKenzie SM, Alvarez-Madrazo S, Diver LA, Lin J, Stewart PM, Fraser R, Connell JM, Davies E. MicroRNA-24 is a novel regulator of aldosterone and cortisol production in the human adrenal cortex. Hypertension. 2013;62:572&#x2013;578. doi: 10.1161/HYPERTENSIONAHA.113.01102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.113.01102</ArticleId><ArticleId IdType="pubmed">23836801</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong JP, Yang L, Tang JW, Sun P, Hu Q, Qin JW, Xu XM, Sun BC, Tang JH. Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9. Oncol Lett. 2016;12:3905&#x2013;3911. doi: 10.3892/ol.2016.5139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2016.5139</ArticleId><ArticleId IdType="pmc">PMC5104208</ArticleId><ArticleId IdType="pubmed">27895747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho J, Ng KH, Rosen S, Dostal A, Gregory RI, Kreidberg JA. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol. 2008;19:2069&#x2013;2075. doi: 10.1681/ASN.2008020162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2008020162</ArticleId><ArticleId IdType="pmc">PMC2573018</ArticleId><ArticleId IdType="pubmed">18832437</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Yu L, Chiu C, Sun Y, Chen J, Khitrov G, Merkenschlager M, Holzman LB, Zhang W, Mundel P, Bottinger EP. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol. 2008;19:2159&#x2013;2169. doi: 10.1681/ASN.2008030312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2008030312</ArticleId><ArticleId IdType="pmc">PMC2573016</ArticleId><ArticleId IdType="pubmed">18776119</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhandapani MC, Venkatesan V, Rengaswamy NB, Gowrishankar K, Nageswaran P, Perumal V. Association of ACE and MDR1 gene polymorphisms with steroid resistance in children with idiopathic nephrotic syndrome. Genet Test Mol Biomarkers. 2015;19:454&#x2013;456. doi: 10.1089/gtmb.2015.0077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/gtmb.2015.0077</ArticleId><ArticleId IdType="pubmed">26154535</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu-Shengyou, Li Y. Dexamethasone inhibits podocyte apoptosis by stabilizing the PI3K/Akt signal pathway. Biomed Res Int. 2013;2013:326986. doi: 10.1155/2013/326986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/326986</ArticleId><ArticleId IdType="pmc">PMC3655450</ArticleId><ArticleId IdType="pubmed">23710442</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng J, Sun F, Yu PF, Li JX, Yuan D, Chang J, Lin SH. Differential microRNA expression in the serum of patients with nephrotic syndrome and clinical correlation analysis. Int J Clin Exp Pathol. 2015;8:7282&#x2013;7286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525962</ArticleId><ArticleId IdType="pubmed">26261628</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>